These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5933642)

  • 1. Vaccination against human leprosy bacillus infections of mice: protection by BCG given during the incubation period.
    Shepard CC
    J Immunol; 1966 Feb; 96(2):279-83. PubMed ID: 5933642
    [No Abstract]   [Full Text] [Related]  

  • 2. Long lasting BCG protection against leprosy.
    Rodrigues LC; Kerr-Pontes LR; Frietas MV; Barreto ML
    Vaccine; 2007 Sep; 25(39-40):6842-4. PubMed ID: 17728023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of the leprosy component of the Brazilian BCG revaccination trial for assessing BCG effectiveness against leprosy in school children.
    Cunha SS; Dourado I; Barreto ML; Alexander N; Pereira SM; Ichihara Y; Pereira ES; Pedrosa V; Maroja F; Ribas C; Rodrigues LC
    Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):8-15. PubMed ID: 15217320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal BCG protection against leprosy: a study in Manaus, Brazilian Amazon.
    Cunha SS; Rodrigues LC; Pedrosa V; Dourado IM; Barreto ML; Pereira SM
    Lepr Rev; 2004 Dec; 75(4):357-66. PubMed ID: 15682973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy.
    Zodpey SP
    Indian J Public Health; 2004; 48(2):70-7. PubMed ID: 15709589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India.
    Zodpey SP; Ambadekar NN; Thakur A
    Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Report on the effect of vaccination with BCG in the protection against mycobacterium infections].
    Rojas-Espinosa O
    Rev Latinoam Microbiol; 1976; 18(1):7-10. PubMed ID: 1070775
    [No Abstract]   [Full Text] [Related]  

  • 9. BCG vaccination protects against leprosy in Venezuela: a case-control study.
    Convit J; Smith PG; Zuniga M; Sampson C; Ulrich M; Plata JA; Silva J; Molina J; Salgado A
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):185-91. PubMed ID: 8371026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: a case-control study.
    Zodpey SP; Shrikhande SN; Kulkarni SW; Maldhure BR
    Indian J Public Health; 2007; 51(3):184-9. PubMed ID: 18229442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of a sustained protection against murine leprosy in C3H mice vaccinated with extracts of Mycobacterium lepraemurium in admixture with Mycobacterium bovis (BCG).
    Turcotte R; Lemieux S
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):494-500. PubMed ID: 6763006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative leprosy vaccine trial in south India.
    Gupte MD; Vallishayee RS; Anantharaman DS; Nagaraju B; Sreevatsa ; Balasubramanyam S; de Britto RL; Elango N; Uthayakumaran N; Mahalingam VN; Lourdusamy G; Ramalingam A; Kannan S; Arokiasamy J
    Indian J Lepr; 1998; 70(4):369-88. PubMed ID: 10189587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case-control study of BCG vaccination as a risk factor for leprosy and tuberculosis in western Kenya.
    Orege PA; Fine PE; Lucas SB; Obura M; Okelo C; Okuku P
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):542-9. PubMed ID: 8151184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ILEP organisations should strive for high BCG coverage in communities at risk of leprosy.
    Velema JP; Ogbeiwi OI
    Lepr Rev; 2007 Jun; 78(2):88-101. PubMed ID: 17824479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Raipur, India.
    Rahete NP; Zodpey SP; Kamble KM
    Indian J Public Health; 2007; 51(2):86-90. PubMed ID: 18240467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The protective efficacy of BCG against leprosy in São Paulo, Brazil].
    Lombardi C; Pedrazzani ES; Pedrazzani JC; Ferreira Filho P; Zicker F
    Bol Oficina Sanit Panam; 1995 Nov; 119(5):415-21. PubMed ID: 8540997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationales for vaccines against leprosy.
    Bloom BR
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):505-9. PubMed ID: 6368414
    [No Abstract]   [Full Text] [Related]  

  • 18. What is the best way to use BCG to protect against leprosy: when, for whom, and how often?
    Smith WC
    Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):48-9. PubMed ID: 15217315
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of bacillus Calmette-Guerin (BCG) vaccination in the prevention of leprosy; a case-finding control study in Nagpur, India.
    Zodpey SP; Shrikhande SN; Salodkar AD; Maldhure BR; Kulkarni SW
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):309-15. PubMed ID: 9934357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG vaccination against leprosy.
    Rees RJ
    Int J Lepr Other Mycobact Dis; 1966; 34(2):186-90. PubMed ID: 5950071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.